A small change in your in­box each morn­ing

As of last week, you may have no­ticed a small change in your email: Se­nior Ed­i­tor Am­ber Tong has of­fi­cial­ly tak­en over the End­points News Ear­ly Edi­tion that each week­day morn­ing wraps up break­ing bio­phar­ma news from around the globe.

Am­ber joined End­points five years ago, and since 2018 she’s shared the Ear­ly Edi­tion’s “from” line with Ar­salan Arif, our co-CEO and pub­lish­er. Am­ber has writ­ten close to 2,000 sto­ries for End­points in that time. She’s de­vel­oped au­thor­i­ta­tive news judg­ment, has grown in­to an ex­pert writer on the bio­phar­ma sec­tor, and is the per­son who makes our news­room hum be­fore many of our read­ers are awake.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER